EFFACLAR BB BLUR
Natural health product licensed in Canada
- Licence holder
- Laboratoires La Roche-Posay Canada
- NPN or DIN-HM
- 80057330
- Status
- Active licence
- Licence date
- 15 January 2015
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- TPD Cat IV/LS
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Dioxyde de titane | 10.66 % |
Non-medicinal ingredients
Acétate de dl-alpha tocophéryle, Silylate de silice, C.I. 77491, Linoléate de rétinyle, Tridécane, Diméthicone, C.I. 77499, Hydroxyde d'aluminium, Polymère croisé de diméthicone, Undécane, Stéaroyl glutamate de disodium, C.I. n° 77891, Perlite, C.I. 77492
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Tout âge | Not specified | 1 Crème | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
SPF 24.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057330
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.